X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES CADILA HEALTHCARE JUBILANT LIFE SCIENCES/
CADILA HEALTHCARE
 
P/E (TTM) x 26.3 32.1 82.0% View Chart
P/BV x 5.4 6.0 90.5% View Chart
Dividend Yield % 0.3 0.8 42.7%  

Financials

 JUBILANT LIFE SCIENCES   CADILA HEALTHCARE
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
CADILA HEALTHCARE
Mar-17
JUBILANT LIFE SCIENCES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs187460 40.6%   
Low Rs65305 21.3%   
Sales per share (Unadj.) Rs364.392.1 395.6%  
Earnings per share (Unadj.) Rs6.814.8 46.2%  
Cash flow per share (Unadj.) Rs24.518.5 132.6%  
Dividends per share (Unadj.) Rs3.003.20 93.8%  
Dividend yield (eoy) %2.40.8 284.7%  
Book value per share (Unadj.) Rs164.968.0 242.5%  
Shares outstanding (eoy) m159.281,023.74 15.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.2 8.3%   
Avg P/E ratio x18.425.8 71.3%  
P/CF ratio (eoy) x5.120.7 24.8%  
Price / Book Value ratio x0.85.6 13.6%  
Dividend payout %43.821.6 202.9%   
Avg Mkt Cap Rs m20,061391,581 5.1%   
No. of employees `0006.216.9 36.7%   
Total wages/salary Rs m11,05215,002 73.7%   
Avg. sales/employee Rs Th9,383.05,594.5 167.7%   
Avg. wages/employee Rs Th1,786.9890.1 200.8%   
Avg. net profit/employee Rs Th176.3899.9 19.6%   
INCOME DATA
Net Sales Rs m58,03494,295 61.5%  
Other income Rs m1911,286 14.8%   
Total revenues Rs m58,22495,581 60.9%   
Gross profit Rs m5,78619,036 30.4%  
Depreciation Rs m2,8123,750 75.0%   
Interest Rs m3,237450 719.4%   
Profit before tax Rs m-7216,122 -0.4%   
Minority Interest Rs m-286338 -84.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-3 -71,496.7%   
Tax Rs m6961,289 54.0%   
Profit after tax Rs m1,09015,168 7.2%  
Gross profit margin %10.020.2 49.4%  
Effective tax rate %-965.98.0 -12,080.6%   
Net profit margin %1.916.1 11.7%  
BALANCE SHEET DATA
Current assets Rs m29,28060,223 48.6%   
Current liabilities Rs m38,91253,058 73.3%   
Net working cap to sales %-16.67.6 -218.4%  
Current ratio x0.81.1 66.3%  
Inventory Days Days8470 120.8%  
Debtors Days Days5188 57.5%  
Net fixed assets Rs m55,71272,984 76.3%   
Share capital Rs m1551,024 15.1%   
"Free" reserves Rs m20,96868,576 30.6%   
Net worth Rs m26,26569,600 37.7%   
Long term debt Rs m17,16924,684 69.6%   
Total assets Rs m88,606152,207 58.2%  
Interest coverage x1.036.8 2.7%   
Debt to equity ratio x0.70.4 184.3%  
Sales to assets ratio x0.70.6 105.7%   
Return on assets %4.910.3 47.6%  
Return on equity %4.221.8 19.0%  
Return on capital %11.617.9 64.5%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00421,280 103.4%   
Fx outflow Rs m11,74910,874 108.0%   
Net fx Rs m10,25510,406 98.6%   
CASH FLOW
From Operations Rs m8,02613,495 59.5%  
From Investments Rs m-1,744-29,103 6.0%  
From Financial Activity Rs m-4,44723,158 -19.2%  
Net Cashflow Rs m1,8347,556 24.3%  

Share Holding

Indian Promoters % 45.6 74.8 61.0%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 8.3 104.8%  
FIIs % 21.2 5.9 359.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 11.0 191.8%  
Shareholders   23,815 44,069 54.0%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 23, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - SUN PHARMA COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS